title: [Intrasal corticosteriods prescription to allergic rhinoconjunctivitis and rhinosinusitis during pediatric ages].
abstract: The different diseases that affect the upper respiratory tract, like allergic rhinitis, rhinoconjunctivitis, and rhinosinusitis have inflammation as their main pathophysiological component. Affects approximately 25% of the adults and 40% of the children. Intranasal corticosteroids (INSs) are considered the most effective treatment for the management of allergic rhinoconjunctivitis. Unlike antihistamines or antileukotrienes, INSs have a more profound effect on nasal congestion and the related sleep disturbance and daytime somnolence resulting from nasal congestion that affect their everyday quality of life. We review INSs mechanism of action, pharmacological properties of the different INSs, their therapeutic use and give our suggestions for their proper use.
authors.affiliation: Instituto Privado de Alergia, Inmunología y Vías Respiratorias (INPAIR), Córdoba, Veracruz, México. sacre_1@hotmail.com
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Sacre Hazouri
authors.forename: Carlos
authors.initials: C
authors.lastname: de la Torre González
authors.forename: Ana Luisa
authors.initials: AL
authors.lastname: López González
authors.forename: Ricardo
authors.initials: R
authors.lastname: Alvarez Vega
mesh_terms: D000284:Administration, Oral; D002648:Child; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*
chemical_list: D005938:Glucocorticoids